ID
37355
Beschreibung
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form documents blood (products) and IV fluids given to the participant and is to be filled in repeatedly during the study, as appropriate.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Stichworte
Versionen (1)
- 20.07.19 20.07.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
20. Juli 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Blood Products
- StudyEvent: ODM
Beschreibung
Blood Products and Blood Supportive Care Products
Alias
- UMLS CUI-1
- C0456388 (Blood product)
- SNOMED
- 410652009
- LOINC
- LP32808-5
- UMLS CUI-2
- C0018938 (Hematologic Agents)
- SNOMED
- 373708006
Beschreibung
hidden
Datentyp
text
Alias
- UMLS CUI [1]
- C2348184 (Sequence Number)
Beschreibung
please specify "OTBP = Other Blood Product" and "OTBSC = Other Blood Supportive Care Product"
Datentyp
text
Alias
- UMLS CUI [1]
- C0456388 (Blood product)
- SNOMED
- 410652009
- LOINC
- LP32808-5
- UMLS CUI [2]
- C0018938 (Hematologic Agents)
- SNOMED
- 373708006
Beschreibung
if applicable
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1521902 (To specify)
- UMLS CUI [1,2]
- C0205394 (Other)
- SNOMED
- 74964007
- LOINC
- LP21049-9
- UMLS CUI [1,3]
- C0456388 (Blood product)
- SNOMED
- 410652009
- LOINC
- LP32808-5
Beschreibung
if applicable
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1521902 (To specify)
- UMLS CUI [1,2]
- C0205394 (Other)
- SNOMED
- 74964007
- LOINC
- LP21049-9
- UMLS CUI [1,3]
- C0018938 (Hematologic Agents)
- SNOMED
- 373708006
Beschreibung
Quantity or Dose
Datentyp
integer
Alias
- UMLS CUI [1]
- C0178602 (Dosage)
- SNOMED
- 260911001
- LOINC
- LP7180-5
- UMLS CUI [2]
- C1265611 (Quantity)
- SNOMED
- 246205007
- LOINC
- LP202968-6
Beschreibung
Blood Products and Blood Supportive Care Products Unit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519795 (Unit of Measure)
- SNOMED
- 767524001
- UMLS CUI [1,2]
- C0456388 (Blood product)
- SNOMED
- 410652009
- LOINC
- LP32808-5
- UMLS CUI [2,1]
- C0018938 (Hematologic Agents)
- SNOMED
- 373708006
- UMLS CUI [2,2]
- C1519795 (Unit of Measure)
- SNOMED
- 767524001
Beschreibung
Start Date/Time
Datentyp
datetime
Alias
- UMLS CUI [1]
- C3897500 (Start Date and Time of Procedure)
Ähnliche Modelle
Blood Products
- StudyEvent: ODM
C1264639 (UMLS CUI [1,2])
C0018938 (UMLS CUI-2)
C0018938 (UMLS CUI [2])
C0205394 (UMLS CUI [1,2])
C0456388 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C0018938 (UMLS CUI [1,3])
C1265611 (UMLS CUI [2])
C0456388 (UMLS CUI [1,2])
C0018938 (UMLS CUI [2,1])
C1519795 (UMLS CUI [2,2])
Keine Kommentare